603259.SH
XD药明康
SSE · Healthcare · Medical - Diagnostics & Research · CN
CNY 155.84
−4.31%Margins
Gross margin
49.4%
EBITDA margin
56.6%
EBIT margin
52.4%
Net margin
41.7%
FCF margin
24.1%
23.9%
Return on equity
18.7%
Return on assets
27.3%
Return on invested capital
0.46x
Asset turnover
CNY 17.6B
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026